Vicarious Surgical Inc. (RBOT) Earnings History
Annual and quarterly earnings data from 2019 to 2025
Loading earnings history...
RBOT EPS Growth (CAGR)
Compound annual growth rate of diluted earnings per share
CAGR (Compound Annual Growth Rate) shows the annualized growth rate of EPS over the specified period. A higher CAGR indicates stronger earnings momentum.
RBOT Profitability Analysis
Margin trends over time
| Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| 2025 | - | - | - |
| 2024 | - | - | - |
| 2023 | - | - | - |
| 2022 | - | - | - |
| 2021 | - | - | - |
Download Data
Export RBOT earnings history in CSV or JSON format
Free sign-in required to download data
Vicarious Surgical Inc. (RBOT) Earnings Overview
As of May 8, 2026, Vicarious Surgical Inc. (RBOT) reported trailing twelve-month net income of -$42M, reflecting +21.2% year-over-year growth. The company earned $-6.29 per diluted share over the past four quarters.
Looking at the long-term picture, RBOT's historical earnings data spans multiple years. The company achieved its highest annual net income of $5M in fiscal 2022.
Vicarious Surgical Inc. is currently reporting a net loss, though operating performance should be evaluated in the context of growth investments and industry dynamics View revenue history →
Compared to peers including ISRG ($2.98B net income, 28.4% margin), MASI ($76M net income, -9.9% margin), SSYS (-$104M net income, -18.9% margin), RBOT has comparable earnings metrics. Compare RBOT vs ISRG →
RBOT Earnings vs Peers
Earnings metrics vs comparable public companies
RBOT Historical Earnings Data (2019–2025)
7 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | -$50M | +20.6% | -$51M | $-8.45 | - | - |
| 2024 | -$63M | +11.0% | -$67M | $-10.72 | - | - |
| 2023 | -$71M | -1478.1% | -$81M | $-14.60 | - | - |
| 2022 | $5M | +114.6% | -$80M | $1.21 | - | - |
| 2021 | -$35M | -173.5% | -$38M | $-10.92 | - | - |
| 2020 | -$13M | -38.2% | -$13M | $-3.76 | - | - |
| 2019 | -$9M | - | -$10M | $-1.70 | - | - |
See RBOT's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs RBOT Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare RBOT vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonRBOT — Frequently Asked Questions
Quick answers to the most common questions about buying RBOT stock.
Is RBOT growing earnings?
RBOT EPS is $-6.29, with earnings growth accelerating to +21.2%. This exceeds the 5-year CAGR of N/A. TTM net income reached $-42M.
What are RBOT's profit margins?
Vicarious Surgical Inc. net margin is N/A, with operating margin at N/A. Below-average margins reflect competitive or cost pressures.
How consistent are RBOT's earnings?
RBOT earnings data spans 2019-2025. The accelerating earnings trend is +21.2% YoY. Historical data enables comparison across business cycles.